IPAD-DB ID | C00825 |
Name | Brazilin |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 6 H 1 4 O 5 |
Molecular Weight | 286.28 g/mol |
IUPAC Name | (6aS, 11bR)-7, 11b-dihydro-6H-indeno[2, 1-c]chromene-3, 6a, 9, 10-tetrol |
InChI | InChI=1S/C16H14O5/c17-9-1-2-10-14(4-9)21-7-16(20)6-8-3-12(18)13(19)5-11(8)15(10)16/h1-5, 15, 17-20H, 6-7H2/t15-, 16+/m0/s1 |
InChIKey | UWHUTZOCTZJUKC-JKSUJKDBSA-N |
Canonical SMILES | C1C2=CC(=C(C=C2C3C1(COC4=C3C=CC(=C4)O)O)O)O |
PubChem CID | 73384 |
DrugBank Accession Number | - |
CAS Registry Number | 474-07-7 |
Molecular Weight(Computed by SwissADME) | 286.28 |
Hac(Computed by SwissADME) | 21 |
Volume(Computed by ADMETlab 2.0) | 279.199 |
Density(Computed by ADMETlab 2.0) | 1.025 |
nRing(Computed by ADMETlab 2.0) | 4 |
MaxRing(Computed by ADMETlab 2.0) | 17 |
nHet(Computed by ADMETlab 2.0) | 5 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 20 |
Flexibility(Computed by ADMETlab 2.0) | 0 |
Stero Centers(Computed by ADMETlab 2.0) | 2 |
LogS(Computed by ADMETlab 2.0) | -3.174 |
LogD(Computed by ADMETlab 2.0) | 2.178 |
logP(Computed by ADMETlab 2.0) | 2.183 |
TPSA(Computed by SwissADME) | 90.15 |
Hbond Acceptor(Computed by SwissADME) | 5 |
Hbond Donor(Computed by SwissADME) | 4 |
Rotatable Bonds(Computed by SwissADME) | 0 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.95 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |